Proof-of-concept Study on Dyspnea Analysis Via GapCO2
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Patients presenting to the emergency department with acute dyspnea undergo arterial blood gas measurement and monitoring of transcutaneous capnography using the TCM5 monitor. The aim of this study is to determine whether GapCO2, the difference between transcutaneous and arterial pCO2 (PaCO2 - PtcCO2), is correlated with the congestive or non-congestive origin of dyspnea.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Patient presenting with acute dyspnea defined by a sensation of respiratory discomfort with at least one of the following criteria: RR ≥ 22 and/or SpO2 < 95%
Arterial blood gas sampling performed as part of care
Inclusion less than 1 hour after arrival time to the emergency department
Disqualifiers
Temperature greater than or equal to 37.5°C
Patient who has already received a diuretic or vasodilator treatment in the emergency department or by a prehospital medical team
Systolic blood pressure less than or equal to 100 mmHg and/or signs of peripheral hypoperfusion
Inability to express refusal to participate in the study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov